InTake Care: Development and Validation of an Innovative, Personalized Digital Health Solution for Medication Adherence Support in Cardiovascular Prevention
Launched by ISTITUTO AUXOLOGICO ITALIANO · Jan 26, 2024
Trial Information
Current as of September 04, 2025
Recruiting
Keywords
ClinConnect Summary
The InTake Care trial is studying a new digital health tool designed to help people with high blood pressure (hypertension) take their medications more consistently. Many patients struggle to stick to their medication plans, which can lead to serious health risks. This trial will test whether a personalized approach, using affordable technology like voice assistants connected to a web interface for their doctors, can improve medication adherence. The tool will be tailored to different types of users to make it more effective.
To participate in this trial, you need to be over 18 years old, have a diagnosis of essential hypertension, and be taking at least one blood pressure medication. You'll also need a stable internet connection and be able to provide written consent. However, those with certain conditions like significant communication issues or severe mental health disorders will not be eligible. If you join, you can expect to use this innovative tool to help track and manage your medication, and your progress will be monitored throughout the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (\>18 years old) patients
- • History of essential hypertension
- • Treatment with at least one antihypertensive drug for which dedicated plasma essay is available
- • wireless internet connection available at patients' home
- • stable clinical conditions
- • written informed consent
- Exclusion Criteria:
- • insufficient technological literacy to manage vocal assistant
- • dementia or significant psychiatric disorders
- • conditions significantly limiting vocal communication (deafness, significant speech disorders, poor knowledge of Italian language)
- • pregnancy or breastfeeding
- • active cancer (except basal cell skin carcinoma)
- • upper limb amputation
About Istituto Auxologico Italiano
Istituto Auxologico Italiano is a prominent Italian research institute dedicated to advancing medical science and improving patient care through innovative clinical research. With a strong focus on metabolic diseases, cardiovascular health, and neuropsychological disorders, the institute integrates clinical practice with cutting-edge research to foster the development of new therapeutic strategies. Committed to ethical standards and patient safety, Istituto Auxologico Italiano collaborates with various national and international partners, contributing significantly to the global medical community while ensuring high-quality care and support for its patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milano, , Italy
Patients applied
Trial Officials
Grzegorz Bilo, MD, PhD
Principal Investigator
Istituto Auxologico Italiano
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported